PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$25.88M
Total Shares
17.37M
Net Share Change
-508.9K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Patient Capital Management
$25.88M17.37M shares
TRIM-508.9K(-2.8%)